Cargando…

WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity

Detalles Bibliográficos
Autores principales:	Takahashi, Nobuyuki, Zhao, Chen, Rajan, Arun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625794/ https://www.ncbi.nlm.nih.gov/pubmed/31304461 http://dx.doi.org/10.21037/med.2019.03.03

Ejemplares similares

WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
por: Suzuki, Mikito, et al.
Publicado: (2019)

Best practices and guidelines for the management of thymic epithelial tumors
por: Giaccone, Giuseppe, et al.
Publicado: (2019)

Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
por: Ballman, Madison, et al.
Publicado: (2022)

The impact of radiomics in predicting oncologic behavior of thymic epithelial tumors
por: Ozawa, Yoshiyuki, et al.
Publicado: (2019)

Deciphering the biology of thymic epithelial tumors
por: Rajan, Arun, et al.
Publicado: (2019)

The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review
por: Rajan, Arun, et al.
Publicado: (2021)

Bridging over troubled waters: the doubling time and histological subtypes of thymic epithelial tumors
por: Kashima, Jumpei, et al.
Publicado: (2020)

Induction chemotherapy for locally advanced thymic epithelial tumors: consideration from the RYTHMIC prospective cohort
por: Nakagawa, Kazuo
Publicado: (2019)

An overview: ongoing systemic therapy trials in thymic epithelial tumors around the world-will anything “hit”?
por: Merveilleux du Vignaux, Claire, et al.
Publicado: (2021)

On the staging of thymic epithelial neoplasms
por: Suster, David, et al.
Publicado: (2019)

Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?
por: Zhao, Chen, et al.
Publicado: (2019)

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
por: Tateo, Valentina, et al.
Publicado: (2020)

Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review
por: Agrafiotis, Apostolos C., et al.
Publicado: (2023)

Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives
por: Ao, Yong-Qiang, et al.
Publicado: (2023)

Advancement in Diagnostic Imaging of Thymic Tumors
por: Gentili, Francesco, et al.
Publicado: (2021)

The immune landscape of human thymic epithelial tumors
por: Xin, Zhongwei, et al.
Publicado: (2022)

Thymic epithelial tumors diagnosis and management: the importance of an international multidisciplinary approach
por: Molina, Thierry Jo
Publicado: (2019)

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)

Immune checkpoints in thymic epithelial tumors: challenges and opportunities
por: Girard, Nicolas
Publicado: (2019)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
por: Gong, Ruining, et al.
Publicado: (2021)

Epigenetics of Thymic Epithelial Tumors
por: Nicolì, Vanessa, et al.
Publicado: (2023)

Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors
por: Su, Yongchao, et al.
Publicado: (2022)

Cancer environmental immunotherapy: starving tumor cell to death by targeting TGFB on immune cell
por: Huang, Xing, et al.
Publicado: (2021)

Novel Biologic Therapies for Thymic Epithelial Tumors
por: Chen, Yuanbin, et al.
Publicado: (2014)

The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

Tumor immunity is related to (18)F‐FDG uptake in thymic epithelial tumor
por: Imai, Hisao, et al.
Publicado: (2021)

Thymic Epithelial Tumors: An Evolving Field
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors
por: Ohm, Birte, et al.
Publicado: (2022)

Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”?
por: Farr, Andrew G., et al.
Publicado: (1998)

A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
por: Sinha, Uttam K., et al.
Publicado: (2023)

Growth of thymic epithelial tumors and thymic cysts: Differential radiological points
por: Kim, Hyungjin, et al.
Publicado: (2019)

Unraveling the Immune Microenvironment of Thymic Epithelial Tumors: Implications for Autoimmunity and Treatment
por: Masaoutis, Christos, et al.
Publicado: (2022)

Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
por: Shirakawa, Toshiro, et al.
Publicado: (2017)

“Hot topics” in thymic epithelial tumors: a special series from the ITMIG 2019 annual meeting
por: Marino, Mirella, et al.
Publicado: (2021)

The role of [(18)F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors
por: Kaira, Kyoichi, et al.
Publicado: (2011)

Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology
por: Moser, Bernhard, et al.
Publicado: (2014)

Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors
por: Janik, Stefan, et al.
Publicado: (2019)

Tumor Microenvironment in Thymic Epithelial Tumors: A Narrative Review
por: Agrafiotis, Apostolos C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_osoebcbc8ml24la8ab88v8q336